The
Brazilian
Journal
of
INFECTIOUS
DISEASES
w w w . e l s e v i e r . c o m / l o c a t e / b j i d
Case
report
Severe
infective
endocarditis
with
systemic
embolism
due
to
community
associated
methicillin-resistant
Staphylococcus
aureus
ST630
Beiwen
Zheng
a,b,
Saiping
Jiang
c,
Zemin
Xu
d,
Yonghong
Xiao
a,b,∗,
Lanjuan
Li
a,b aStateKeyLaboratoryforDiagnosisandTreatmentofInfectiousDiseases,TheFirstAffiliatedHospital,SchoolofMedicine,Zhejiang University,Hangzhou,ChinabCollaborativeInnovationCenterforDiagnosisandTreatmentofInfectiousDiseases,Hangzhou,China
cDepartmentofPharmacy,TheFirstAffiliatedHospital,SchoolofMedicine,ZhejiangUniversity,Hangzhou,China dNingboInstituteofMicrocirculationandHenbane,Ningbo,China
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received15May2014 Accepted1July2014
Availableonline1September2014
Keywords: Community-acquiredMRSA Infectiveendocarditis ST630 Surgicaltherapy
a
b
s
t
r
a
c
t
Community-associatedmethicillin-resistantStaphylococcusaureus(CA-MRSA)are increas-inglycausinginfectiveendocarditisoverthepastdecade.Herewereportahealthyman whodevelopedasevereacuteinfectiveendocarditiswithsystemicembolismcausedby CA-MRSA.Thestrainwasrecoveredfromrepeatedbloodculturesandwascharacterizedusing moleculardetectionandgenotyping.TheS.aureusisolatewastypedasST630SCCmecVwith
spa-typet4549,agrI/IVandwasPVL-negative.Thisistheonlycasereport,toour knowl-edge,ofCA-MRSAinfectiveendocarditisinChina.Thiscasehighlightstheemergenceand geographicalspreadoflife-threateningCA-MRSAinfectionwithinChina.
©2014PublishedbyElsevierEditoraLtda.
Introduction
Since the first genuine community-associated
methicillin-resistant Staphylococcus aureus (CA-MRSA) infection was
reported inAustralia in the early 1990s, the emergence of
CA-MRSA infection has increased in recent years all over
the world. CA-MRSA is primarily associated with healthy
individualskinandsofttissueinfections.Additionally, inva-sive diseases, including bacteremia, infective endocarditis (IE),osteomyelitis,andhemorrhagicnecrotizingpneumonia,
∗ Correspondingauthorat:StateKeyLaboratoryforDiagnosisandTreatmentofInfectiousDisease,TheFirstAffiliatedHospital,Schoolof
Medicine,ZhejiangUniversity,Hangzhou310003,China.
E-mailaddresses:xiao-yonghong@163.com,ljli@zju.edu.cn(Y.Xiao).
alsohavebeenreported.Infectiveendocarditiscanseriously damageheartvalvesandcauseotherseriouscomplications, associatedwithsignificantmorbidityandmortality,anditis lethal if notpromptly treated with appropriateantibiotics, regardlessofwhethersurgeryisperformed.1However,despite
improveddiagnostictechniquesand advancesintreatment
options,neitheritsincidencenormortalityhasdecreasedin thepastyears.2S.aureusisaleadingcauseofleft-sided
infec-tiveendocarditisindevelopingcountries,nevertheless,only
sporadic cases ofendocarditis caused byCA-MRSA among
healthyindividualshavebeenreported.3Herewedescribethe
http://dx.doi.org/10.1016/j.bjid.2014.07.006
firstcaseofinfectiveendocarditiscomplicatedwithsystemic
embolismduetoanovelCA-MRSAST630inChina,whichwas
successfullytreatedwithacombinationofantimicrobialsand surgicaltherapy.
Case
presentation
A49-year-old previouslyhealthy manwas admittedtothe
hospitalwitha10-dayhistoryofchills,fever,anddyspneain August2011.Hehadnohistoryofsurgeryorintravenousdrug use,andhadnonotablemedicalrecord.Atthetimeof hos-pitaladmission,physicalexaminationrevealedapulserate of62beats permin,respiratoryrateof20breathspermin,
andbloodpressureof125/83mmHg.Asystolicmurmurwas
bestheardattheapex.Hewasfebrile(40.7◦C)andhehada minorabrasion onleft foot.Therestofhisphysical exami-nationwasunremarkable.Pertinentlaboratoryinvestigations revealed white blood cellcount of23,100/mm3, with94.5%
neutrophils,3.2%lymphocytes,and2.3%mononuclearcells, plateletsof40,000/mm3andC-reactiveproteinof58.6mg/L.
The patient was hospitalized for a presumptive diagnosis
ofsepticemia. Empiricalantibiotics were started with van-comycinandlevofloxacin(0.5gq8h)therapy.
Duringthenexttwodays,echocardiographyrevealedlarge vegetationonthe anterior mitralvalveleaflet (3cm×3cm) withmoderatemitralvalveregurgitation(Fig.1A)Spiral
com-putedtomography(CT)showedrenalandsplenicinfarction
(Fig.1B).CTscansofthebraindemonstratedmultiple low-densitybilaterallesionsofthetemporallobes,rightparietal
lobe and occipital lobe, suggestive of cerebral embolism.
Preliminary blood cultures grew S. aureus susceptible to
ciprofloxacin,rifampicin,linezolid,vancomycin,tetracycline,
sulfamethoxazole, levofloxacin and fosfomycin but
resis-tanttopenicillin,oxacillin,clindamycin,cefazolin,cefoxitin,
cefuroxime,and erythromycin,as determinedon the basis
ofCLSIdiscdiffusionstandards.Adiagnosisofacute infec-tiveendocarditiswithsystemicembolismcausedbyCA-MRSA wasthusconsidered.Becauseofhisimpairedrenalfunction and bacterial susceptibility profile,the patient was treated withintravenouslinezolid(600mgq12h)andfosfomycin(8.0g q12h).
Onday10,hisclinical statusworsenedwithepisodesof tachypnea,pinkfrothysputumandoxygensaturation(SpO2)
decreased rapidly to 83% with ventilator support. Further-more, renal function deteriorated, oliguria and right lower extremitytissuenecrosisappeared.Embolizationoftheright commoniliacarteryandrightinternalandexternaliliac arter-ieswasseenonechocardiography(Fig.1C).Hesubsequently
developeda comawith aGlasgow ComaScale (GCS) score
of 6. His clinical condition deteriorated such that he was transferredtotheICU,and replacementofthemitralvalve
was accomplished witha 29-mmCarbomedics mechanical
valve.Consideringthepresenceofcomaand fever(39.8◦C) postoperatively,brainCTwasobtainedandshowedmultiple low-densitylesionsintemporallobes,rightparietallobe,and occipitallobe,suggestiveofcerebralembolism(Fig.1D). Levo-floxacin(0.75gqd)wasaddedtohisantibioticregimen.After 10daysofintravenousantibiotics,thepatientregained con-sciousness(GCSscoreof9)andmadeagoodclinicalrecovery.
Onday35,hewastransferredtoasecondaryhospital,and linezolidtherapywascontinuedforeightweeks.Herecovered uneventfullyandwaswellatthelastfollow-upinNovember 2013.
Microbiological
investigations
The isolate recovered from the vegetation was first
iden-tified by the VITEK 2 system and then identified with
MicroFlex LTinstrument (BrukerDaltonics).Matrix-assisted laserdesorption/ionizationtimeofflightmassspectrometry (MALDI-TOF-MS)basedfingerprintanalysisofextracted pro-teinsyieldedapatternsimilartothatofconfirmedS.aureus
isolates, Flexcontrol3.0softwareandBiotyper 2.0database (Bruker Daltonics)identified the isolateasS. aureuswitha
maximum score value of2.166 (data not shown). In
addi-tion toMALDI-TOF-MS analysis,16S rRNA sequencing was
performed inordertoidentifythe originofthe bacteriain
the vegetation.Thesequenceofthe PCRproductwas
com-paredwithsequencesofcloselyrelatedspeciesinGenBank byusingBLAST.Sequencingofthe16SrRNAgeneofthe iso-latesshowedthattherewas100%identitywiththe16SrRNA genesequenceoftheisolateofS.aureus(GenBankaccession no.JN102565),confirmingthattheisolatewasS.aureus.
Tofurtherinvestigatethegeneticbasisofthestrain,
mul-tilocus sequence typing (MLST),a methodthat uses seven
housekeepinggenes (arcC,aroE, glpF,gmk,pta,tpi and yqiL)
forgeneticidentification,andresultwasassignedby compar-isonwiththeS.aureusMLSTdatabase(http://www.mlst.net/).
The staphylococcal chromosomal cassette (SCC) mec type
(I–V) was also determined. The spa type was analyzed
by sequencing of the PCR product of the spa gene, and
the spa type was assigned using an online spa database
(http://www.spaserver.ridom.de/).Detectionoftheaccessory gene regulator (agr) allelegroup was accordingtoPCR and sequencing.Likewise,theantimicrobialdrugresistancegenes
(mecA, msrA, msrB, ermA,ermB, ermC and blaZ)were
deter-mined. The presenceofgene encodingPVL (lukF/lukS) and
other virulencerelatedgenes(sea,seb,sec,sed,see,seg,seh, sei,sej,sem,sen,seo,sek,sel,sep,seq,hla,hlb,hld,hlg,hlg2,eta, etb,lukE,lukM,bsaAandedin,)wereinvestigatedbyPCR.The presenceofadhesiongenes(cna,clfA,clfB,fnbA,efbandicaA)
werealsodeterminedbyPCRandsequencing.
TheCA-MRSAisolatewastypedassequencetype(ST)630
SCCmecVwithspa-typet4549,agrI/IVandwasPVL-negative.
WeconfirmedthepresenceofmecA,ermCandblaZgenesby
PCRandsequencing.ThegenomeoftheMRSAisolateencoded threehemolysingenes(hlb,hldandhlg2)andfiveadhesion genes(clfA,clfB,fnbA,efbandicaA)(Fig.1E).
Discussion
IE is a rare entity of CA-MRSA presentation, especially in
non-intravenousdrugusers(IVDU),andCA-MRSA
endocardi-tis casesare mostly restricted to IVDUs, especiallyamong
HIV-infected patients with the USA300 strain. To date, 11
previously reported cases of infective endocarditis caused
byCA-MRSA,excludingcasesinIDVUpatientswere
A
B
C
D
bp 2000 1000 750 250 500 100Marker mecA ermC blaZ clfA clfB icaA efb fnbA hlb hld hlg2
E
Fig.1–Infectiveendocarditiscomplicatingsystemicembolism(thearrowsindicateareasofinterest)anddetectionofkey genes.(A)ColorDopplerechocardiographyshowingthevegetationattachedtotheanteriormitralvalveleaflet.(B)Spiral
computedtomographyshowingrenalinfarction.(C)Echocardiographicexaminationshowingembolizationoftheright
commoniliacarteryandrightinternalandexternaliliacarteries.(D)Computedtomographyofthebrainshowingmultiple low-densitylesions.(E).Detectionofantimicrobialgenes,virulence-relatedgenesandadhesiongenesbyPCRamplification. Lane1,molecularweightmarker;lane2,mecA;lane3,ermC;lane4,blaZ;lane5,clfA;lane6,clfB;lane7,icaA;lane8,efb;
lane9,fnbA;lane10,hlb;lane11,hld;lane12,hlg2.
described here) are shown in Table 1. Most reported
CA-MRSAIEcaseswerePVL-positiveinthelist; onlytwocases werePVL-negative,althoughonecasewasuntyped.Ofthe11 casescollected here,sixstrainswereSCCmec typeIV, three
strainswereSCCmectypeVandtwountypedstrains.These
resultsareconsistentwiththe previousfindings.CA-MRSA
infections have mostly been epidemiologically linked with
strainsharboringtheSCCmectypeIV/VandPVL.4Ontheother
hand,mostCA-MRSAclonesaresusceptibletomanynon-
-lactamdrugs,andthepatientinthiscasewastreatedwith
linezolid,vancomycin,levofloxacinandfosfomycinaccording totheguidelines.AcomprehensivestudyofCA-MRSAin
Chi-nesechildrenshowsthatmostoftheCA-MRSAstrainswere
PVL-negative, and ST59-MRSA-IVa witht437 was the most
commonclone.5AtpediatrichospitalsinfiveChinesecities
in2005–2006,ofthe73MRSAclinicalisolates,thedetection rateofthePVLgenewas30%(22/73),andtheseincludedthe ST1,ST910,ST88,ST59,andST338geneticbackgrounds.6
How-ever,theprevalenceofCA-MRSAinBeijingwasrareamong
Table1–SummaryofreportedcasesofCA-MRSAinfectiveendocarditisamongpatientswithnoriskfactors.
Age/sex Country/ region
Symptoms Valve SCCmec type
Treatmenta pvlb Sequence
typec
Outcome Ref.
20M Taiwan Septicembolism Mitral NA Va
Vegetationremoval
NA NA Recovered 12
47M Italy Sepsis Mitral NA Va,Ami
Valvereplacement
NA ST5 Recovered 13
22M USA Bacteremia, septicembolism
Aortic TypeIV Cfz,Lnz Pos NA Recovered 14
37M USA Abscesses Mitral TypeIV Va,Lnz Valvularsurgery
Pos NA Recovered 15
44M USA Septicembolism Aortic TypeIV Va
Incisionand drainage
Pos NA Recovered 15
27M Brazil Headache,fever Mitral TypeIV Cro,Va Pos NA Recovered 16
39F Korea Highfever,chill Mitral TypeIV Pen,VaandGen Surgicalintervention
Neg ST72 Recovered 17
61F Italy Fever,weakness, pain,dyspnea
Mitraland aortic
TypeV Va,DapandRif Pericardialpuncture Pos ST152 Recovered 18 79F Argentina Bacteremia, brainabscesses Aorticand mitral
TypeIV Va,Ts Pos ST5 Died 19
19M Australia Brainabscesses, renalmycotic aneurysmand endophthalmitis
Aortic NA Va,Fa,RifandCt Pos ST93 Recovered 20
2M Taiwan Pneumonia Tricuspid TypeV Tei,Ts Pos ST59 Recovered 9
49M China Systemic embolism, bacteremia
Mitral TypeV Lev,Fos,VaandLnz Valvereplacement
Neg ST630 Recovered Current case
F,female;M,male.
a Va,vancomycin;Ami,amikacin;Cfz,cefazolin;Lnz,linezolid;Cro,ceftriaxone;Pen,penicillin-G;Gen,gentamicin;Dap,daptomycin;Rif,
rifampicin;Ts,trimethoprimsulfamethoxazole;Fa,fusidicacid;Ct,co-trimoxazole;Tei,teicoplanin;Lev,levofloxacin;Fos,fosfomycin.
b pvl,Panton-Valentineleukocidin;Pos,positive;Neg,negative. c NA,notavailable.
CA-MRSAamongpatientswithSSTIsinHongKongrevealed
thattheisolatesofCA-MRSAstrainsprimarilybelongedtothe
ST30-HKU100cloneandST59-HKU200clone.8Incontrast,a
previoushealthypreschoolchildwasdevelopedIEand
pneu-moniawithpleuraleffusionbytheendemicCA-MRSAclone
ST59inTaiwan.9
Inthiscase,wereportthefirstinfectiveendocarditisdueto novelCA-MRSAST630inmainlandChina.ST630clonewas ini-tiallyisolatedamongmethicillinsusceptibleS.aureus(MSSA)
asdescribed inS. aureusMLSTdatabase and hasnotbeen
reportedinassociationwithhumaninfection.UsingMLSTand
eBURST,theST630MRSAlineagecanbegroupedasclonal
complex8(CC8),alargecomplexofrelatedMSSAandMRSA
genotype.ST630cloneisavariantofST8clonewiththeallele atthearcClocus,andST8isdescribedastheputativeancestral
genotypeofanothersubgroupwithinCC8.Frequent
conver-sionofMSSAtoMRSAbyhorizontaltransferofSCCmechas
beendescribed.10ItislikelythatST630MRSAoriginatedfrom
ST630MSSA and ST630 MRSAindependently developedby
multipleevolutionarypathways.Toourknowledge,ourcase wasuniqueinbeingthefirstdocumenteddestructiveinvasive infectioncasecausedbyST630SCCmecV.
ThepathogeneticmechanismsofCA-MRSAinfectionare
notfullyunderstood.However,adhesinshavebeenidentified ascritical mediatorsimplicatedinthe inductionof experi-mentalS.aureusendocarditisinrats.11Theisolateofthiscase
encodes five adhesiongenes mightpartly contributeto its
pathogenesis.Inthepresenthigh-riskpatient,prompt antimi-crobialtreatmentandearlysurgerywerepivotalforavoiding afatalresult.Despitebeingaboutonlyonecase,thisreport
highlights the geographical spread and emergence of
life-threateningCA-MRSAinfectionwithinChina.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
Acknowledgements
This work was supported bythe National Natural Science
FoundationofChina(GrantNos.81361138021and81301461)
andtheScientificResearchFoundationofZhejiangProvincial
HealthBureau(GrantNo.2012KYB083).
r
e
f
e
r
e
n
c
e
s
1.ThunyF,GrisoliD,CollartF,etal.Managementofinfective endocarditis:challengesandperspectives.Lancet. 2012;379:965–75.
2.BashoreTM,CabellC,FowlerJrV.Updateoninfective endocarditis.CurrProblCardiol.2006;31:274–352.
3. FowlerJrVG,MiroJM,HoenB,etal.Staphylococcusaureus endocarditis:aconsequenceofmedicalprogress.JAMA. 2005;293:3012–21.
4. HsuLY,KohYL,ChlebickaNL,etal.EstablishmentofST30as thepredominantclonaltypeamongcommunity-associated methicillin-resistantStaphylococcusaureusisolatesin Singapore.JClinMicrobiol.2006;44:1090–3.
5. GengW,YangY,WuD,etal.Molecularcharacteristicsof community-acquired,methicillin-resistantStaphylococcus aureusisolatedfromChinesechildren.FEMSImmunolMed Microbiol.2010;58:356–62.
6. WangL,LiuY,YangY,etal.Multidrug-resistantclonesof community-associatedmeticillin-resistantStaphylococcus aureusisolatedfromChinesechildrenandtheresistance genestoclindamycinandmupirocin.JMedMicrobiol. 2012;61:1240–7.
7. ZhaoC,LiuY,ZhaoM,etal.Characterizationofcommunity acquiredStaphylococcusaureusassociatedwithskinandsoft tissueinfectioninBeijing:highprevalenceofPVL+ST398. PLoSONE.2012;7:e38577.
8. HoPL,ChuangSK,ChoiYF,etal.Community-associated methicillin-resistantandmethicillin-sensitiveStaphylococcus aureus:skinandsofttissueinfectionsinHongKong.Diagn MicrobiolInfectDis.2008;61:245–50.
9. LeeCY,ChangTM,LinCJ,etal.Infectiveendocarditiscaused bycommunity-associatedmethicillin-resistantStaphylococcus aureusinapreviouslyhealthypreschoolchild.JMicrobiol ImmunolInfect.2014;47:257–60.
10.EnrightMC,RobinsonDA,RandleG,etal.Theevolutionary historyofmethicillin-resistantStaphylococcusaureus(MRSA). ProcNatlAcadSciUSA.2002;99:7687–92.
11.QueYA,FrancoisP,HaefligerJA,etal.Reassessingtheroleof Staphylococcusaureusclumpingfactorandfibronectin-binding proteinbyexpressioninLactococcuslactis.InfectImmun. 2001;69:6296–302.
12.LinJC,WuJS,ChangFY.Community-acquired
methicillin-resistantStaphylococcusaureusendocarditiswith
septicembolismofpoplitealartery:acasereport.JMicrobiol ImmunolInfect.2000;33:57–9.
13.PistellaE,CampanileF,BongiornoD,etal.Successful treatmentofdisseminatedcerebritiscomplicating methicillin-resistantStaphylococcusaureusEndocarditis unresponsivetovancomycintherapywithlinezolid.ScandJ InfectDis.2004;36:222–5.
14.CrumNF.Theemergenceofsevere,community-acquired methicillin-resistantStaphylococcusaureusinfections.ScandJ InfectDis.2005;37:651–6.
15.BahrainM,VasiliadesM,WolffM,etal.Fivecasesofbacterial endocarditisafterfurunculosisandtheongoingsagaof community-acquiredmethicillin-resistantStaphylococcus aureusinfections.ScandJInfectDis.2006;38:702–7.
16.FortesCQ,EspanhaCA,BustorffFP,etal.Firstreportedcaseof infectiveendocarditiscausedbycommunity-acquired methicillin-resistantStaphylococcusaureusnotassociatedwith healthcarecontactinBrazil.BrazJInfectDis.2008;12:541–3.
17.LeeSY,KimJY,KimJH,etal.Acaseofprimaryinfective endocarditiscausedbycommunity-associated methicillin-resistantStaphylococcusaureusinahealthy individualandcolonizationinthefamily.YonseiMedJ. 2009;50:152–5.
18.BassettiM,NiccoE,MalgorzataM,etal.Community associatedmethicillinresistantStaphylococcusaureus (CA-MRSA)infectiveendocarditisinItaly.JInfect. 2010;61:353–5.
19.SolaC,LamberghiniRO,CiarlantiniM,etal.Heterogeneous vancomycin-intermediatesusceptibilityina
community-associatedmethicillin-resistantStaphylococcus aureusepidemicclone,inacaseofInfectiveEndocarditisin Argentina.AnnClinMicrobiolAntimicrob.2011;10:15.
20.TownellNJ,MunckhofWJ,NimmoG,etal.
Community-associatedmethicillin-resistantStaphylococcus aureusendocarditis‘downunder’:caseseriesandliterature review.ScandJInfectDis.2012;44:536–40.